Coaching GLP-1 + B12
$249.00/ month
Quantity
Includes telehealth consult, personalized dosing plan, and expert accountability coaching
This package includes access to a licensed telehealth provider through our partner network (e.g., Qualiphy), as well as dedicated coaching to support your weight loss and wellness goals. All prescriptions are issued only if medically appropriate following a comprehensive medical review. If you are not approved, you will receive a full refund. Renu does not prescribe or sell medication directly—approved prescriptions are fulfilled exclusively by licensed U.S. compounding pharmacies.
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes and now widely used for sustainable fat loss and appetite regulation. Combined with methylcobalamin (vitamin B12), this compound offers enhanced energy, nutrient support, and long-term weight management—especially during calorie-restricted phases.
Semaglutide (GLP-1 Agonist)
Slows gastric emptying and increases satiety
Suppresses appetite and food cravings
Supports stable blood sugar and insulin sensitivity
Promotes long-term metabolic health
Vitamin B12 (Methylcobalamin)
Boosts red blood cell production and energy
Reduces fatigue and nausea often linked to GLP-1 use
Enhances nerve health and metabolic resilience
✅ Powerful appetite suppression and portion control
✅ Targeted fat loss with lean muscle preservation
✅ Improved blood sugar regulation
✅ Boosted energy, mood, and mental clarity
✅ Reduced risk of weight regain with continued coaching
✅ Ideal for prediabetic, PCOS, and insulin-resistant clients
Form: Sterile compounded injectable solution
Base Medication: Semaglutide (GLP-1 receptor agonist)
Additive: Methylcobalamin (Vitamin B12)
Administration: Subcutaneous injection (weekly or as directed)
Storage: Refrigerate after opening
Dosing Protocol: Customized by licensed medical provider
Purity: ≥ 99% pharmaceutical-grade
Fulfillment: Licensed U.S. compounding pharmacies only
Medically supervised, HIPAA-compliant telehealth model
No grey-market or “research use only” products
Custom clinical protocols tailored to your body and goals
Experienced accountability coaching for long-term results
U.S. pharmacy fulfillment with ongoing professional oversight
Wilding JPH, et al. “Once-weekly Semaglutide in adults with overweight or obesity.” NEJM (2021)
Davies MJ, et al. “Semaglutide for weight loss in adults with obesity or overweight.” Lancet (2021)
Butler AE, et al. “Role of GLP-1 receptor agonists in metabolic regulation.” Diabetes Therapy (2020)
Stabler SP. “Vitamin B12 deficiency.” NEJM (2013)
Semaglutide + B12 is available by prescription only and must be used under the supervision of a licensed medical provider. Compounded medications are not FDA-approved and are dispensed only after medical clearance. This content is for educational purposes and should not be considered medical advice.
Peptide Therapy Disclaimer
Although our partner pharmacies use only FDA-approved ingredients that are pharmaceutical-grade and highly regulated, compounded prescriptions are not FDA approved
This website and any content provided herein are for informational and educational purposes only.
We are not a medical provider. All medications, including peptide therapies, are prescribed and managed exclusively by licensed medical professionals through a third-party medical group, Qualiphy PC. Any medical evaluations, diagnoses, prescriptions, or treatment decisions are made solely by those providers following a telehealth consultation and in accordance with applicable state and federal laws.
Our role is to support clients with non-medical coaching services such as fitness guidance, nutrition planning, and lifestyle accountability. We do not diagnose, treat, or prescribe medications. We are not responsible for the outcomes or effects of any medical treatment prescribed by third-party providers.
Always consult with a licensed healthcare provider before starting or stopping any medical treatment. If you have questions or concerns related to your medication, please contact the prescribing provider.